Bristol based Neuronostics raises £3m led by Empirical Ventures and The FSE Group
Summary
Neuronostics raised £3 million in seed funding to accelerate the rollout of BioEP, its EEG-based digital biomarker platform for suspected epilepsy. The company plans to expand NHS adoption, complete US regulatory work, and prepare the product for pharmaceutical trials. It says BioEP has already been validated across multiple NHS sites and is designed to deliver a fast, objective report from routine EEG data. The company also formed a strategic partnership with Stratus to support future US deployment.
Funding
Amount
$3.8M
Total raised
Date
June 30, 2026
Announcement date
Investors
NERC, Ascension Ventures, The FSE Group
Lead investors
Company
neuronostics.com
Funded company
Classifications
industries
HealthTech
applications
Statistics and Mathematics
AskAI Classifications
Labels
HealthTech
Medical Software
Digital Biomarkers
Linked Companies
Neuronostics Ltd
$1M to $5M